 |
|
|
| |
Substantial comorbidities and rising economic burden in real-world non-alcoholic fatty liver disease (NAFLD)/ non-alcoholic steatohepatitis (NASH) patients with compensated cirrhosis (CC):
A large German claims database study
|
| |
| |
Reported by Jules Levin
EASL 2018 April 11-15 Paris France
Canbay A1, Meise D2, Haas JS2
1Department of Gastroenterology, Hepatology and Infectiology, University of Magdeburg Medical School, 2Xcenda GmbH
|
| |
|
|
|
|
|
